HBC March 2020 News Bulletin

Thursday, March 26, 2020


Message from the HBC

HBC would like to re-emphasize our support for you as you navigate through these challenging times.  Please feel free to reach out to anyone in our group for support.   If you have questions on your grants, or need to look into supplements for funding, we are here to help.   Just let us know.  Stay safe and well.


Biomedical Sciences Symposium Postponed

Due to the Coronavirus Disease 2019 (COVID-19) outbreak, the Biomedical Sciences Symposium will be postponed until late summer or early fall of 2020. The organizers will announce the rescheduled symposium date as soon as possible.  All updates will  be posted on the Biomedical Sciences Symposium website.


J.R. & Inez Jay Fund Proposal Submission

Applications for the 2020 J.R. & Inez Jay Fund proposal submission are currently being accepted.  The instructions and application forms are available on the HBC website.  Two awards not to exceed $30,000 each will be funded this year.  Please be sure to apply by the April 3, 2020 deadline.


NIH Updates and Information on Emergency Competitive Revision to Existing NIH Awards

  • The NIH announced that emergency supplemental funds may be available to existing NIH awards due to the disaster and public health emergency declared earlier this month.  To get more information, review the full announcement PA-20-135.  
  • The NIH has set up a webpage that provides COVID-19 information for NIH applicants and recipients.  The webpage provides guidance for proposal submission and award management, human subjects and clinical trials, animal welfare, and peer review.  Also, posted on that page, are funding opportunities specific to COVID-19.  However, that page is not updated daily to reflect new funding opportunities.  Be sure to check NIH’s Active Funding Opportunities and Notices to view the latest COVID-19 Notices of Special Interest (NOSIs). 
  • Notice on Policy Regarding Minimum Level of Effort for the NIH National Cancer Institute (NCI) funded awards was issued on March 3, 2020.  This notice indicates the new required minimum level of effort the principal investigators (and project leaders on multi-project grants) must commit to be eligible for NCI funding through R01/U01, P01 and R21 grant mechanisms.  The minimum requirements for R35, P50, and P30 grant mechanisms remain unchanged.



    Minimum Level of Effort in calendar months/year (%)



    1.8 months (15%)


    1.2 months (10%) each



    1.8 months (15%)

    Project PI

    1.2 months (10%)

    PI and Project PI

    3 months (25%)

    Core Leader

    0.6 months (5%)



    0.6 months (5%)

  • Due to the COVID-19 outbreak, the NIH Regional Seminar  in Baltimore (April 20 - April 22) has been cancelled and registrations are being refunded.  The next NIH regional seminar will be held in Nashville, TN, October 28-30, 2020.  In addition, the 21st Annual U.S. Department of Health and Human Services (HHS) Small Business Programs Conference has been postponed.  Updates will be sent to registered attendees and will be posted on their website.
  • Reminder: the NIH eRA modules and data will not be available from 8 am ET on April 17 to 8 pm ET on April 20 due to NIH’s cloud migration.  Any affected due dates will be extended for a full two days.


O’Leary SSC Satellite Office Update

The O’Leary SSC is discontinuing the west campus satellite hours effective immediately.  If you need to meet with the SSC, please contact them.

Grant Submission Deadlines

October 2, 2020
NIH deadline for the Maximizing Investigators' Research Award (R35) for Early Stage Investigators.

October 5, 2020
NIH standard deadline for Research Grants and Cooperative Agreements (R01 and U01)– new submissions.

October 12, 2020
NIH standard deadline for Research Career Development (K series) – new submissions.

October 16, 2020
NIH standard deadline for Other Research Grants and Cooperative Agreements (R03, R21, R33, R21/R33, R34, R36, UH2, UH3, UH2/UH3) – new submissions.

Recent Awards

Meredith Hartley, Assistant Professor, Department of Chemistry, was awarded $50,000 by the American Thyroid Association for her project entitled “Thyroid hormone signaling during remyelination.”

Jennifer Robinson, Assistant Professor, Department Chemical and Petroleum Engineering, was awarded $50,000 by the KU Medical Center Research Institute for her project entitled: “Deciphering Sex Differences in Adolescent Knee Meniscal Injury and Regeneration” and  $50,000 by the Howard Hughes Medical Institute for her project entitled: “Promoting Temporomandibular Joint Fibrochondrogenesis through the use of an Estrogen Receptor Alpha Selective Agonist to Treat Osteoarthritis.”

Jingxin Wang, Assistant Professor, Department of Medicinal Chemistry, was awarded $50,000 by Bionexus KC for his project entitled “Small Molecule *Oligonucleotide Conjugate for the Treatment of Spinal Muscular Atrophy (SMA) with Improved Specificity.”

Liang Xu, Professor, Department of Molecular Biosciences, was awarded $50,000 by the University of Utah Health for his project entitled: “Novel therapeutic strategy for renal fibrosis by targeting RNA-binding protein HuR targeting.”

One of 34 U.S. public institutions in the prestigious Association of American Universities
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
5th nationwide for service to veterans —"Best for Vets: Colleges," Military Times
KU Today